KOSPIHolding Companies002790

AMOREPACIFIC Holdings

₩27,050▲ 0.56%2026-11-18 close
Market Cap
₩2.1T
Turnover
₩1.6B
Volume
60K
Shares out.
76.5M
PER
17.8×
PBR
0.6×
EPS
₩1,478
Dividend Yield
1.52%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩400 per share · Prices as of the 2026-11-18 close

01

Report overview

Operating Profit Recovers, But Attributable Earnings Slip Again

AMOREPACIFIC Holdings' operating profit rose to KRW 368 billion in 2025, but profit attributable to controlling shareholders fell to KRW 124 billion, and that figure has declined for two consecutive quarters since its first-quarter 2026 peak.

  1. 1

    Operating profit has grown in 2024 and 2025 after the 2023 low, and the 2025 operating margin of 8.0% was the highest of the 2022 to 2025 period.

  2. 2

    Profit attributable to controlling shareholders peaked at KRW 252 billion in 2024 and fell 50.8% to KRW 124 billion in 2025, moving in the opposite direction from operating profit.

  3. 3

    Third-quarter 2026 revenue rose 8.9% year on year to KRW 1.21 trillion and operating profit rose 24.7% to KRW 130.1 billion, while profit attributable to controlling shareholders fell 11.0% to KRW 33.2 billion.

  4. 4

    Preliminary third-quarter 2026 results for subsidiary Amorepacific, announced on October 29, 2026, showed domestic operating profit up 42%, while the group's beauty brand companies such as innisfree declined.

  5. 5

    The price-to-book ratio sits below 1x, and because controlling shareholders hold less than half of total equity, the valuation debate centers on how the holding structure is read.

02

Business structure

AMOREPACIFIC Holdings is a pure holding company that owns stakes in its subsidiaries and directs their businesses. Its operating revenue consists of dividend income, royalty income, service income and rental income. As of 2023, the consolidated segments were cosmetics at 95.3% and other businesses at 4.7%.

Its main subsidiary, Amorepacific, makes and sells cosmetics, household goods and health functional foods. The cosmetics segment includes luxury and premium brands such as Sulwhasoo, HERA, LANEIGE, IOPE and Estra, while the daily beauty segment includes Ryo, Mise en Scene, Happy Bath and Illiyoon.

According to the 2023 business report, the holding company had eight domestic subsidiaries, including Amorepacific, innisfree, ETUDE, Amos Professional, ESPOIR and Osulloc. Sales run through domestic direct sales, duty-free, and overseas subsidiaries and exports.

In the third quarter of 2026, Amorepacific's domestic revenue rose 11% to KRW 620.5 billion, and overseas revenue rose 12% to KRW 495.5 billion, preliminary figures announced on October 29, 2026.

Overseas, Estra more than doubled in North America, led by Sephora and Amazon, and also more than doubled in Japan together with COSRX. By contrast, the combined revenue of beauty brand companies such as innisfree, ETUDE, ESPOIR and Amos Professional fell 12%.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩1.1T₩104.3B9.4%
2025Q4₩1.3T₩54.8B4.4%
2026Q1₩1.2T₩137.8B11.3%
2026Q2₩1.3T₩122.8B9.8%
2026Q3₩1.2T₩130.1B10.8%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩4.5T₩271.9B₩62.2B6.0%1.9%17.1%
2023₩4T₩152B₩119.3B3.8%3.6%17.0%
2024₩4.3T₩249.3B₩252B5.9%7.6%22.2%
2025₩4.6T₩368B₩124B8.0%3.6%21.2%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-16

04

Earnings analysis

Annual revenue went from KRW 4.49 trillion in 2022 to KRW 4.02 trillion in 2023, a 10.5% decline, then rose to KRW 4.26 trillion in 2024 (up 5.9%) and KRW 4.62 trillion in 2025 (up 8.5%). 2023 was the smallest year and 2025 the largest in the 2022 to 2025 period.

Operating profit was KRW 272 billion in 2022, KRW 152 billion in 2023 (down 44.1%), KRW 249 billion in 2024 (up 64.0%) and KRW 368 billion in 2025 (up 47.6%). The operating margin moved from 6.0% in 2022 to 3.8% in 2023, 5.9% in 2024 and 8.0% in 2025.

Profit attributable to controlling shareholders was KRW 62.2 billion in 2022, KRW 119.3 billion in 2023 (up 91.7%) and KRW 252 billion in 2024 (up 111.3%), before falling to KRW 124 billion in 2025 (down 50.8%).

Net profit including non-controlling interests was KRW 292.2 billion in 2025, against KRW 652.9 billion in 2024, and the gap between the two measures was wide in both years.

In 2025 operating profit rose while attributable profit fell, so the business report income statement is needed to judge how non-operating items and the allocation to non-controlling interests contributed. Operating cash flow grew from KRW 183.5 billion in 2022 to KRW 629.7 billion in 2025.

The debt ratio was 21.2% at the end of 2025, when total equity was KRW 7.24 trillion, of which controlling shareholders held KRW 3.48 trillion, and total liabilities were KRW 1.53 trillion.

Quarterly operating profit fell from KRW 104.3 billion in the third quarter of 2025 to KRW 54.8 billion in the fourth quarter (down 47.5% quarter on quarter), then recovered to KRW 137.8 billion in the first quarter of 2026 (up 151.6%), followed by KRW 122.8 billion in the second quarter and KRW 130.1 billion in the third quarter (up 24.7% year on year).

Profit attributable to controlling shareholders went from KRW 2.95 billion in the fourth quarter of 2025 to a first-quarter 2026 peak of KRW 56.2 billion, then fell to KRW 41.8 billion in the second quarter and KRW 33.2 billion in the third quarter.

The sum for the last four quarters was KRW 134.2 billion, so the operating profit recovery has not yet carried through to profit attributable to controlling shareholders.

05

Industry analysis

In Korean cosmetics, growth is broadening from luxury skincare centered on Sulwhasoo into dermo-cosmetics and hair care.

In the third quarter of 2026, Amorepacific's domestic operating margin rose to 13.6%, about 3 percentage points higher than a year earlier, which the company attributed to lower discounting and a larger share of high-margin brands and channels.

Store closures and the expansion of e-commerce and multi-brand shops were also cited as factors. Revenue from dermo brands Estra and Illiyoon rose more than 40%, and hair care posted double-digit growth, according to reporting from October 2026.

Group revenue has grown for nine consecutive quarters, which supports the top-line case. Overseas, the company describes a multi-brand growth structure in the Americas, and the Chinese business returned to profitability in the third quarter of 2025 after a restructuring, according to the company.

Beauty brand companies, however, shrank as they streamlined distribution channels, leaving a clear divergence within the group. For a holding company, the share price reflects subsidiary earnings, the value of stakes and a holding-company discount, so industry trends should be read subsidiary by subsidiary.

Simple multiple comparisons with other holding companies are limited because the subsidiaries operate in very different industries.

06

Outlook

The mid-to-long-term targets the company presented when announcing its third-quarter 2025 results are entry into the global top three in premium skincare and overseas revenue reaching 70% of the total. The strategy rests on three pillars: portfolio upgrading, global expansion and AI-based operational innovation.

As of the third quarter of 2026, Estra's revenue rose more than 80% on growth in Korea, North America and Japan, and the brand is expanding distribution in Europe and China. Illiyoon's total revenue rose more than 60% in the quarter and its overseas revenue grew sixfold.

According to October 2026 reporting, dermo brands Estra and Illiyoon expanded to the mid-20% range of group revenue. Overseas growth, however, slowed from 28% in the second quarter of 2026 to 12% in the third quarter, and that deceleration is a point to monitor.

The progress of the restructuring at the beauty brand companies is another variable for the operating profit structure. The next disclosures are the fourth-quarter 2026 preliminary results and the 2026 annual business report.

In the annual report, the key checks are how the 2026 operating margin and profit attributable to controlling shareholders compare with 2025.

07

Valuation

PER
17.8×
PBR
0.6×
ROE
3.9%
EPS
₩1,478
BPS
₩46,164
Dividend per share
₩400

Valuation for a holding company changes substantially depending on which earnings base is used.

Profit attributable to controlling shareholders fell from KRW 252 billion in 2024 to KRW 124 billion in 2025, and the last four quarters total KRW 134.2 billion, so the earnings multiple reads differently depending on the year chosen.

On the balance sheet side, controlling shareholders held less than half of total equity at the end of 2025, which makes net asset value attributable to them the more relevant reference. The price-to-book ratio sits below 1x, which is read as a price below net asset value.

How much value the market assigns to subsidiaries, and how large a holding-company discount applies, differ across analysts.

Operating profit rose to KRW 368 billion in 2025 while attributable profit has not kept pace for several periods, so earnings quality and the allocation to non-controlling interests need to be read together.

Dividends can cushion earnings volatility at a holding company, but capacity depends on attributable profit and cash flow. Comparison against a historical PER band has limited weight given how volatile attributable profit has been.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-16

08

Bull factors

Recovery in domestic profitability

In the third quarter of 2026, Amorepacific's domestic operating profit rose 42% to KRW 84.6 billion and the domestic operating margin reached 13.6%, preliminary figures announced on October 29, 2026. The company cited lower discounting and a larger share of high-margin brands and channels. Reporting linked this to the growth in consolidated operating profit at the holding company.

Dermo and hair care widen growth

Estra's revenue rose more than 80%, Illiyoon's rose more than 60%, and hair care posted double-digit growth in the third quarter of 2026. Coverage noted that the growth base is widening from luxury-centered skincare into dermo and hair care.

Consecutive group revenue growth

Group revenue has grown for nine consecutive quarters through the third quarter of 2026, and third-quarter revenue rose 8.9% to KRW 1.21 trillion. Overseas revenue of KRW 495.5 billion grew 12% at the subsidiary level, helping to offset domestic movement. The quarter combined top-line growth with higher operating profit.

09

Bear factors

Consecutive declines in attributable profit

Profit attributable to controlling shareholders peaked at KRW 56.2 billion in the first quarter of 2026, then fell to KRW 41.8 billion in the second quarter and KRW 33.2 billion in the third. In the third quarter, operating profit rose 24.7% while attributable profit fell 11.0% year on year. The gap between operating profit growth and attributable profit remains.

Weakness at beauty brand companies

Combined third-quarter 2026 revenue of beauty brand companies including innisfree, ETUDE, ESPOIR and Amos Professional fell 12%, and operating profit fell 29%, based on preliminary subsidiary data. The company linked the decline to channel streamlining, but the margin improvement has not spread evenly across the group.

Slower overseas growth

Overseas revenue growth at the subsidiary slowed from 28% in the second quarter of 2026 to 12% in the third quarter. The growth depends on a small number of high-growth brands such as Estra and COSRX, so a slowdown could weigh on group revenue. The gap to the mid-term target of 70% overseas revenue share remains.

10

Risk factors

Earnings volatility and non-operating items

Net profit including non-controlling interests was KRW 292.2 billion in 2025, down from KRW 652.9 billion in 2024, and attributable profit fell 50.8% to KRW 124 billion in 2025.

Because operating profit and attributable profit moved in opposite directions in some periods, the reading of results depends on the earnings base. Non-operating items and the allocation to non-controlling interests can drive that difference.

Channel and overseas concentration

Revenue at subsidiary Amorepacific is spread across duty-free, e-commerce, multi-brand shops and overseas subsidiaries. Results can shift with channel policies or changes in demand, and the concentration of revenue in a few fast-growing overseas brands is another variable.

Cost of subsidiary restructuring

Beauty brand companies are in the middle of channel streamlining and business restructuring, and their combined operating profit fell 29% in the third quarter of 2026.

If the restructuring lasts longer, cost and revenue adjustments may continue, which could limit how far group profitability improves until results are visible.

11

What to watch next

  1. Fourth-quarter 2026 preliminary results (expected around late January 2027)

    Check whether fourth-quarter 2026 operating profit and profit attributable to controlling shareholders continue the pattern since the first-quarter 2026 peak. The key question is whether operating profit gains carry through to attributable profit.

  2. 2026 annual business report filing (by end of March 2027)

    Check how 2026 annual revenue, operating margin, debt ratio and operating cash flow changed from 2025. Also check whether profit attributable to controlling shareholders rose above KRW 124 billion in 2025.

  3. First-quarter 2027 results (expected around late April 2027)

    Check whether the domestic operating margin at subsidiary Amorepacific holds around 13%, and whether the combined operating profit decline at the beauty brand companies narrows.

12

Overall view

AMOREPACIFIC Holdings' operating profit bottomed in 2023 and rose in both 2024 and 2025, with the 2025 operating margin reaching 8.0%.

Profit attributable to controlling shareholders, however, peaked at KRW 252 billion in 2024, fell to KRW 124 billion in 2025, and has declined for two consecutive quarters since its first-quarter 2026 peak.

In the third quarter of 2026, subsidiary Amorepacific's domestic operating profit rose 42%, and dermo and hair care growth stood out, while beauty brand companies declined and overseas growth slowed.

The holding structure means that the share of subsidiary profit belonging to outside shareholders and non-operating items both affect attributable profit. On the balance sheet, controlling shareholders hold less than half of total equity, and the price-to-book ratio sits below 1x.

The next checkpoints are the fourth-quarter 2026 preliminary results and whether the 2026 annual report shows operating profit gains carrying through to attributable profit.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 16 more articles and sources
  1. digitaltoday.co.kr
  2. vegannews.co.kr
  3. dailypop.kr
  4. infostockdaily.co.kr
  5. sidae.com
  6. economytribune.co.kr
  7. vegannews.co.kr
  8. shinailbo.co.kr
  9. digitaltoday.co.kr
  10. apgroup.com
  11. womentimes.co.kr
  12. apgroup.com
  13. apgroup.com
  14. catch.co.kr
  15. k5.co.kr
  16. businesskorea.co.kr

Report written 2026-11-16 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis